KRAS-Variant and Breast Cancer
Webinar – KRAS-Variant and Breast Cancer Did you miss our live webinar on the KRAS-Variant with Dr. Joanne Weidhaas? Watch the replay and learn about how this genetic mutation can impact your…
Read More ➝
Posts
Menopause
Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. Let’s start with Perimenopause… Did you know that women in their 40s (and some…
Read More ➝
New Research: How Inherited DNA -Based Mutations Impact Immunotherapy
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…
Read More ➝
International Women’s Day Profile: Dr. Joanne Weidhaas
Here at MiraKind, we’re constantly inspired by the amazing women who surround us; whether it is scientists and doctors working on our research, or the strong and empowered women who are facing complex health challenges with dignity and grace.
Read More ➝
HRT and The KRAS-Variant
While there are many factors to consider before taking hormone replacement therapy (HRT), understanding your genetic profile can prove invaluable in your decision-making process. Joanne Weidhaas, MD, PhD, and her colleagues published…
Read More ➝
Top 5 Reasons to Give a Charitable Donation this Holiday Season
This time of year, the malls and online stores are filled with shoppers, eager to purchase the perfect gift for friends and loved ones near and far. We may be biased, but…
Read More ➝
Breast Cancer Awareness Month
It’s Breast Cancer Awareness Month, so here at MiraKind, we’re taking a moment to think about the many ways in which breast cancer impacts our community. Many of you may know that…
Read More ➝
Menopause & Myths about Hormone Replacement Therapy
Post Updated February 7, 2022 For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN. So what can we…
Read More ➝
What You Need to Know About Estrogen and the KRAS-variant
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation that predicts an increased risk of cancer. Following this breakthrough, Dr. Weidhaas and…
Read More ➝
Let’s Talk Menopause (Finally)
Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. We all know something about menopause, but just like pregnancy or bungee jumping, you…
Read More ➝
Why you should get your KRAS-variant results
Dear study participants, I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study. While I always enjoy…
Read More ➝
The truth about GWAS and the KRAS-variant
Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice…
Read More ➝
How does breast cancer treatment impact second breast cancer risk?
We are embarking on a study to explore how breast cancer management strategies (e.g., chemotherapy, surgery, hormones) that are used to treat breast cancer, impact breast cancer risk for women with the KRAS-variant.
Read More ➝- « Previous
- 1
- 2
- 3
Disclaimer
Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
